1 active not recruiting, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Unknown 1 |
Follow Cytora Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA) hOMSC300 - Multiple System Atrophy, MSA - Multiple System Atrophy | Phase 1 | Active not recruiting | Cytora Ltd. | 10 | 2022-11-07 | 2025-01-29 |
| Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200 hOMSC200, Placebo - Diabetic Foot, Diabetic Foot Ulcer | Phase 1 | Unknown | Cytora Ltd. | 21 | 2022-01-06 | 2024-03-13 |
Diabetic Foot (1) · Multiple System Atrophy (1) · Shy-Drager Syndrome (1)
Israel (2)